SCHEMBL154709

SCHEMBL154709

CCc1ccc(Nc2ccccn2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
MAPK10 P53779 1/20 0.48
GFER P55789 1/20 0.48
SYK P43405 1/20 0.48
GRM5 P41594 1/20 0.46
KDR P35968 3/20 0.45
FABP1 P07148 1/20 0.43
FABP6 P51161 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 1/20 0.43
CCNK O75909 1/20 0.43
CDK12 Q9NYV4 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LYN P07948 1/20 0.42
SRC P12931 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837237 0.81 CYP1A2 (0.51) CXCR4KMT2AMEN1MAPK10GFER
SCHEMBL152586 0.81 HCAR3 (0.51) KMT2AMEN1SYKGRM5NPC1
SCHEMBL15834054 0.79 NOS3 (0.50) CXCR4KMT2AMEN1MAPK10GFER
Alcohol SCHEMBL11701443 0.77 KMT2A (0.59) CXCR4KMT2AMEN1MAPK10GFER
SCHEMBL26910995 0.77 KMT2A (0.64) CXCR4KMT2AMEN1MAPK10GFER
SCHEMBL29391624 0.77 KMT2A (0.76) CXCR4KMT2AMEN1MAPK10GFER
SCHEMBL221242 0.77 KMT2A (0.76) CXCR4KMT2AMEN1MAPK10GFER
SCHEMBL15779673 0.77 SLC2A1 (0.56) KMT2AMEN1MAPK10GFERKDR
SCHEMBL4943735 0.76 SYK (0.51) KMT2AMEN1MAPK10SYKTP53
SCHEMBL24358152 0.75 SLC2A1 (0.72) KMT2AMEN1NPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CXCR4 464/4885KMT2A 2732/4885MEN1 3912/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CXCR4 464/4885KMT2A 2732/4885MEN1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.